Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Part 1: To evaluate the safety and tolerability, define the maximum tolerated dose (MTD) and dose limiting toxicities (DLTs) if possible, and define the recommended doses and dosing schedules of ODM-207 for Part 2 of the study. Part 2: To further evaluate the safety and tolerability, and preliminary antitumour activity of ODM-207 at the dose levels recommended for further clinical studies in patient populations with selected tumour types.
Critère d'inclusion
- Advanced Solid Tumours